Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fpsyt.2018.00299 http://scihub22266oqcxt.onion/10.3389/fpsyt.2018.00299 C6048357!6048357!30042700     free     free     free       Front+Psychiatry 2018 ; 9 (ä): ä Nephropedia Template TP {{tp|p=30042700|t=2018. Biological Mechanisms of Cancer-Induced Depression |pdf=|usr=}}{{30042700}} gab.com Text Biological Mechanisms of Cancer-Induced Depression JO: Front Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=30042700 #FOAvip Patients with cancer are more likely to develop depression than the general population, which negatively impacts their quality of life and prognosis. In order to identify effective antidepressants catered toward cancer patients, the biology of depression in the context of cancer must be well-understood. Many theories have emerged postulating the mechanisms underlying the development of depressive disorder. Here, we review the role inflammation, a hyperactive hypothalamic-pituitary-adrenal (HPA) axis, and glutamate excitotoxicity may play in cancer-induced depression. Hopefully, novel therapeutics targeting these dysregulated pathways may be potent in ameliorating depressive symptoms in the cancer population. Twit Text FOAVip Biological Mechanisms of Cancer-Induced Depression ????Front Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=30042700 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30042700 #FOAvip English Wikipedia <ref>{{Cite pmid|30042700}}</ref> Biological Mechanisms of Cancer-Induced Depression #MMPMID30042700 Young K; Singh G Front Psychiatry 2018[]; 9 (ä): ä PMID30042700show ga Patients with cancer are more likely to develop depression than the general population, which negatively impacts their quality of life and prognosis. In order to identify effective antidepressants catered toward cancer patients, the biology of depression in the context of cancer must be well-understood. Many theories have emerged postulating the mechanisms underlying the development of depressive disorder. Here, we review the role inflammation, a hyperactive hypothalamic-pituitary-adrenal (HPA) axis, and glutamate excitotoxicity may play in cancer-induced depression. Hopefully, novel therapeutics targeting these dysregulated pathways may be potent in ameliorating depressive symptoms in the cancer population. äBiological Mechanisms of Cancer-Induced Depression (epmc).pdf DeepDyve Pubget Overpricing